Global Influenza Vaccine Market 2016-2022 - Opportunity Analysis Report - Research and Markets
DUBLIN, July 04, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Influenza Vaccine Market Outlook 2022" report to their offering.
Global Influenza Vaccine Market Outlook 2022 unfolds the market dynamics of the influenza vaccine market. The report shows the global influenza vaccine industry being segmented on the basis of major vaccine in the market. Followed by this, important geographies have been highlighted along with their current and future markets outlook till 2022. The report also covers advanced stage pipeline analysis of key players, which list down the influenza vaccines already in Phase III trials. The report identifies and highlights the segments that offer maximum opportunity for growth in the global influenza vaccine market.
The global influenza vaccine industry has reported a significant growth in recent years, and is presenting ample opportunities to the industry's players.
The global influenza vaccine industry has reported a significant growth in recent years, and is presenting ample opportunities to the industry's players. With increasing pandemic as well as seasonal outbreak and rising awareness, the global influenza vaccine market is poised to scale newer acmes. Moreover, introduction of new vaccines, entry of new players, rising R&D investments, evolving government policies, and infrastructure projects are set to further boost the market's growth.
Since the H1N1 pandemic, worldwide authorities have started to adopt proactive approach in the vaccination process. Virus of previous pandemics are still circulating in the environment and in the coming future, they may be classified as strains to be updated in seasonal vaccines. Moreover, a large chunk of global population is affected by influenza-related problems. In such a scenario, huge opportunity lies for industry participants to tap the fast growing market.
The industry analysts studied all the facets of the global influenza vaccine market to portray a crystal clear picture of the current as well as the expected market outlook. Major drivers and trends have been identified that are set to act as catalysts towards boosting the industry's growth, along with roadblocks hindering the market's growth.
The report further highlights the competitive landscape of the global influenza vaccine market, describing the business, financials, and influenza vaccine business of the major industry players. The section is therefore expected to clearly help the reader gain crucial insight into the key market players' performances and strategies for growth. Holistically, the research provides all the pre-requisite information for clients looking to make a debut in this industry, and facilitates them to formulate strategies while going for an investment/partnership in the global influenza vaccine industry.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Influenza Vaccine - Introduction
4. Industry Trends and Drivers
4.1 Increasing Pandemic Outbreak
4.2 Rising Affordability
4.3 Rising Ageing Population
4.4 Development of Universal Flu Vaccine
4.5 Collaborations in the Market
5. Industry Challenges
5.1 Testing and Regulatory Issues
5.2 Low Awareness
5.3 Lack of Medical and Healthcare Infrastructure
6. Global Influenza Vaccine Market Outlook 2022
6.1 Current Market Overview and Future Outlook
6.2 Major Marketed Vaccines
6.2.1 Fluzone/Vaxigrip
6.2.2 FluMist
6.2.3 Fluarix and Flulaval
6.2.4 Anflu
6.2.5 Fluvax/Afluria
6.2.6 Flucelvax and Fluvirin
7. Key Geographical Market
8. Global Influenza Vaccine Market: Pipeline Analysis
9. Global Influenza Vaccine Market: Pricing Analysis
10. Competitive Assessment
Companies Mentioned
- AstraZeneca Plc
- CSL Ltd.
- GlaxoSmithKline Plc (GSK)
- Sanofi
- Sinovac Biotech
For more information visit http://www.researchandmarkets.com/research/dvjxg9/global_influenza
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article